Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04178200
Other study ID # 2019/776
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date December 16, 2019
Est. completion date April 24, 2020

Study information

Verified date November 2019
Source Develi Devlet Hastanesi
Contact Hastane Bashekimligi
Phone +903526216020
Email kayseridhs2@saglik.gov.tr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

It is aimed to determine patient satisfaction (pain assessment during and after the operation) and the initial and total anesthesia durations of eye lid and globe anesthesia after administration of local anesthetic solution only in standard applied volumes (1.5-3 ml). No agents will be added to the local anesthetic agents used in the conventional retrobulbar block in patients who will undergo cataract surgery,


Description:

In this study, 80 patients with American Society of Anesthesiologists (ASA) I-II-III who accepted retrobulbar anesthesia before cataract surgery and who were over 18 years of age and under 90 years of age were included in the study. Not accepting local anesthesia, being under 18 years of age, having problems in communication, having eyelid or eye anomaly, having Parkinson's disease, myopia with axial length ≥ 26 mm, hypersensitivity to local anesthetics or other drugs, and bleeding or other drug-induced clotting problem were determined as exclusion criteria for the investigator's study.

Written informed consent will be obtained from patients eligible for the study according to the above criteria. While obtaining informed consent, it will also be verbally stated that this study does not include any risks other than the risks of standard cataract surgery and retrobulbar block.

Patients taken to the operating room before the operation will be monitored and baseline blood pressure, pulse and peripheral capillary oxygen saturation (SpO2) values will be recorded. 2lt / min oxygen will be administered to patients with a nasal cannula. The normal ocular and valve movements of the patient will be checked and recorded before the procedure. Patients will receive a 20 gauge intravenous (IV) cannula. Before the retrobulbar block is applied, topical anesthesia is provided with 0.5% proparacaine drops and field cleaning with povidone iodine will be performed. The patient will be instructed to look at the finger held by the assistant personnel to bring the eyeball to the neutral position and the local anesthetic mixture will be slowly injected into the retrobulbar area with a 25 gauge ophthalmic needle. For retrobulbar anesthesia, 1.5-3 ml of local anesthetic solution (2% lidocaine, 5% bupivacaine) will be administered to the patients. The maximum treatment duration is 1 day and single dose. Gently massage the eye to disperse the local anesthetic solution and reduce bleeding. After block 1, 3, 5 and 10 minutes ocular movements and valve movements will be evaluated. To do this, patients will be told to look up, down, right and left and be asked to squeeze and open their eyelids. Ocular movements will be scored for each direction separately if normal, 2 if slightly restricted, and 0 if there is no movement (total score 0-8) [1]. In the evaluation of eye lid movements, complete immobility will be scored as 0, partial movement as 1 and normal movement as 2 [2]. The patient's blood pressure, pulse and SpO2 values will be recorded at 5 min intervals throughout the operation. During the operation, the pain of the patients will be assessed by a 3-point scale (0: no pain; 1: uncomfortable; 3: pain). Postoperative ocular and eye lid akinesia scores of the patients will be recorded at 30-minute intervals. Ocular and eye lid akinesia times will be recorded. Any side effects that occur during and after the procedure will be recorded. One day later, patients' responses will be recorded by asking for the first time and the number of times they need analgesics.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 80
Est. completion date April 24, 2020
Est. primary completion date April 24, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria:

1. To accept retrobulbar anesthesia before cataract surgery

2. To be over 18 and under 90

3. Being ASA I-II-III

Exclusion Criteria:

1. Not to accept local anesthesia

2. To be under 18 years

3. Having problems in communication

4. To have lid or eye anomaly

5. Being Parkinson's

6. Being myopia with axial length = 26 mm

7. Hypersensitivity to local anesthetics or other drugs

8. Having bleeding or other drug related clotting problems

Study Design


Intervention

Drug:
Lidocaine 2% Injectable Solution 0.75 ml
0.75 ml of Lidocaine will be added to the anesthetic solution.
Bupivacaine Hcl 0.5% Inj 0.75 ml
0.75 ml of Bupivacaine will be added to the anesthetic solution.
Lidocaine 2% Injectable Solution 1.5 ml
1.5 ml of Lidocaine will be added to the anesthetic solution.
Bupivacaine Hcl 0.5% Inj 1.5 ml
1.5 ml of Bupivacaine will be added to the anesthetic solution.

Locations

Country Name City State
Turkey Develi Hatice Muammer Kocatürk Devlet Hastanesi Develi Kayseri

Sponsors (1)

Lead Sponsor Collaborator
Develi Devlet Hastanesi

Country where clinical trial is conducted

Turkey, 

References & Publications (2)

Barr J, Kirkpatrick N, Dick A, Leonard L, Hawksworth G, Noble DW. Effects of adrenaline and hyaluronidase on plasma concentrations of lignocaine and bupivacaine after peribulbar anaesthesia. Br J Anaesth. 1995 Dec;75(6):692-7. — View Citation

Sarvela PJ. Comparison of regional ophthalmic anesthesia produced by pH-adjusted 0.75% and 0.5% bupivacaine and 1% and 1.5% etidocaine, all with hyaluronidase. Anesth Analg. 1993 Jul;77(1):131-4. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Patient Pain Score patient pain assessed by with pain score of 3 points-scale (0 No pain,1 Not comfortable, 2 Have pain ) Immediately after the surgery
Primary The scores of ocular and eyelid movements Ocular movements will be scored separately for each direction, 2 if normal, 1 if slightly restricted and 0 if no movement. Complete inactivity will be scored as 0, partial movement as 1, and normal movement as 2 in the evaluation of eyelid movements. at 1 minutes after the block
Primary The scores of ocular and eyelid movements Ocular movements will be scored separately for each direction, 2 if normal, 1 if slightly restricted and 0 if no movement. Complete inactivity will be scored as 0, partial movement as 1, and normal movement as 2 in the evaluation of eyelid movements. at 3 minutes after the block
Primary The scores of ocular and eyelid movements Ocular movements will be scored separately for each direction, 2 if normal, 1 if slightly restricted and 0 if no movement. Complete inactivity will be scored as 0, partial movement as 1, and normal movement as 2 in the evaluation of eyelid movements. at 5 minutes after the block
Primary The scores of ocular and eyelid movements Ocular movements will be scored separately for each direction, 2 if normal, 1 if slightly restricted and 0 if no movement. Complete inactivity will be scored as 0, partial movement as 1, and normal movement as 2 in the evaluation of eyelid movements. at 10 minutes after the block
Primary The postoperative scores of ocular and eyelid movements Ocular movements will be scored separately for each direction, 2 if normal, 1 if slightly restricted and 0 if no movement. Complete inactivity will be scored as 0, partial movement as 1, and normal movement as 2 in the evaluation of eyelid movements. at 30 minutes after the operation
Primary The postoperative scores of ocular and eyelid movements Ocular movements will be scored separately for each direction, 2 if normal, 1 if slightly restricted and 0 if no movement. Complete inactivity will be scored as 0, partial movement as 1, and normal movement as 2 in the evaluation of eyelid movements. at 60 minutes after the operation
Primary The postoperative scores of ocular and eyelid movements Ocular movements will be scored separately for each direction, 2 if normal, 1 if slightly restricted and 0 if no movement. Complete inactivity will be scored as 0, partial movement as 1, and normal movement as 2 in the evaluation of eyelid movements. at 90 minutes after the operation
Primary The postoperative scores of ocular and eyelid movements Ocular movements will be scored separately for each direction, 2 if normal, 1 if slightly restricted and 0 if no movement. Complete inactivity will be scored as 0, partial movement as 1, and normal movement as 2 in the evaluation of eyelid movements. at 120 minutes after the operation
Primary The postoperative scores of ocular and eyelid movements Ocular movements will be scored separately for each direction, 2 if normal, 1 if slightly restricted and 0 if no movement. Complete inactivity will be scored as 0, partial movement as 1, and normal movement as 2 in the evaluation of eyelid movements. at 150 minutes after the operation
Primary The postoperative scores of ocular and eyelid movements Ocular movements will be scored separately for each direction, 2 if normal, 1 if slightly restricted and 0 if no movement. Complete inactivity will be scored as 0, partial movement as 1, and normal movement as 2 in the evaluation of eyelid movements. at 180 minutes after the operation
Primary The postoperative scores of ocular and eyelid movements Ocular movements will be scored separately for each direction, 2 if normal, 1 if slightly restricted and 0 if no movement. Complete inactivity will be scored as 0, partial movement as 1, and normal movement as 2 in the evaluation of eyelid movements. at 210 minutes after the operation
Primary The scores of ocular and eyelid movements Ocular movements will be scored separately for each direction, 2 if normal, 1 if slightly restricted and 0 if no movement. Complete inactivity will be scored as 0, partial movement as 1, and normal movement as 2 in the evaluation of eyelid movements. at 240 minutes after the operation
Secondary The need for analgesic and how many times it needs The patients will be asked whether they need analgesia (yes or no), if they need analgesia, they will be asked what time and how many times they take analgesic agents. One day after the surgery
Secondary side effects questionnaire Ophthalmic side effects (Globe perforation, Pain at the injection site, Pressure sensation behind the eye, Subconjunctival hemorrhage, Retrobulbar hemorrhage, hematoma, ecchymosis, diplopia, ptosis) and other side effects (Nausea and vomiting, arrhythmia, Convulsion, Allergy, Weakness) One day after the surgery
See also
  Status Clinical Trial Phase
Completed NCT03663478 - Continuous TQL Block for Elective Cesarean Section Phase 4
Completed NCT04513652 - A Study of the Safety and Anesthetic Effect of AG-920 Topical Ophthalmic Solution Phase 3
Completed NCT05464862 - The Effect of PPB Using 10, 20 and 30 ml of Lidocaine, Study on Volunteers Phase 4
Completed NCT04690647 - The Efficacy of Suprainguinal Fascia Iliaca Compartment Block for Analgesia After Elective Total Hip Replacement. N/A
Completed NCT03245359 - Pain Management After TKA: Comparison of Short- and Long-term Nerve Blocks N/A
Recruiting NCT06028126 - Superficial Parasternal Intercostal Plane Block in Cardiac Surgery Trial N/A
Not yet recruiting NCT05815563 - Validation of Peripheral Perfusion Index in Predicting Successful Supraclavicular Brachial Plexus Block in Pediatrics
Completed NCT01418690 - Changes in Tissue Oxygenation Following Regional Anesthesia N/A
Suspended NCT03291691 - Protective Nerve Stimulation in Regional Anesthesia
Not yet recruiting NCT03545516 - Wound Infiltration as Part of an Opioid Free Pain Management Pathway Following Cesarean Delivery Phase 2
Not yet recruiting NCT05038007 - Pain After Lung Cancer Surgery - Comparing Traditional Versus Prolonged Release Nerve Blockades Phase 2
Terminated NCT03672500 - Perineal Local Infiltration Study N/A
Enrolling by invitation NCT06057090 - Do Therapy Dogs Improve Behavior and Reduce Anxiety in Pediatric Dental Patients? N/A
Recruiting NCT05415865 - The Effect of Local Anesthetic Solution in the Bladder Prior to Botox Injections in the Bladder Phase 3
Recruiting NCT06011005 - Efficacy of Ethyl Chloride Topical Anesthesia Application on the Pain Perception During Intra-oral Injections in Children in Comparison to Benzocaine Gel. N/A
Completed NCT04536311 - Surgical Stabilization of Rib Fractures While Awake or Under Appropriate Sedation by Paravertebral Block N/A
Completed NCT03600454 - The Effect of Anesthesia on Perioperative Muscle Weakness and Neuro-endocrine Stress Response N/A
Recruiting NCT03159338 - Platelet-rich Fibrin on Nerve Regeneration After Bilateral Sagittal Split Osteotomy N/A
Completed NCT02966067 - A Split Mouth Trial to Compare Microneedles vs. Standard Needles in Dental Anaesthetic Delivery N/A
Completed NCT03305666 - Trial of Injected Liposomal Bupivacaine vs Bupivacaine Infusion After Surgical Stabilization of Rib Fractures Phase 4